NorthCrest Asset Manangement’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,431
| Closed | -$110K | – | 648 |
|
|
2025
Q1 | $110K | Buy |
12,431
+316
| +3% | +$2.8K | ﹤0.01% | 582 |
|
|
2024
Q4 | $166K | Sell |
12,115
-519
| -4% | -$7.12K | 0.01% | 549 |
|
|
2024
Q3 | $346K | Buy |
12,634
+34
| +0.3% | +$931 | 0.01% | 457 |
|
|
2024
Q2 | $308K | Hold |
12,600
| – | – | 0.01% | 449 |
|
|
2024
Q1 | $269K | Sell |
12,600
-400
| -3% | -$8.53K | 0.01% | 463 |
|
|
2023
Q4 | $249K | Hold |
13,000
| – | – | 0.01% | 472 |
|
|
2023
Q3 | $209K | Sell |
13,000
-250
| -2% | -$4.01K | 0.01% | 481 |
|
|
2023
Q2 | $307K | Hold |
13,250
| – | – | 0.01% | 439 |
|
|
2023
Q1 | $308K | Buy |
13,250
+1,300
| +11% | +$30.2K | 0.01% | 441 |
|
|
2022
Q4 | $173K | Buy |
11,950
+1,550
| +15% | +$22.4K | 0.01% | 381 |
|
|
2022
Q3 | $198K | Hold |
10,400
| – | – | 0.01% | 422 |
|
|
2022
Q2 | $189K | Hold |
10,400
| – | – | 0.01% | 421 |
|
|
2022
Q1 | $262K | Buy |
+10,400
| New | +$262K | 0.01% | 372 |
|